{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:38:50Z","timestamp":1792168730235,"version":"4.4.0"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:p>\n                    Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vitamin D analogues and calcium supplementation and not replacement of the lacking hormone, as in other hormonal deficiency states. The purpose of this guideline is to provide clinicians with guidance on the treatment and monitoring of chronic HypoPT in adults who do not have end-stage renal disease. We intend to draft a practical guideline, focusing on operationalized recommendations deemed to be useful in the daily management of patients. This guideline was developed and solely sponsored by\n                    <jats:italic>The European Society of Endocrinology<\/jats:italic>\n                    , supported by CBO (Dutch Institute for Health Care Improvement) and based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) principles as a methodological base. The clinical question on which the systematic literature search was based and for which available evidence was synthesized was: what is the best treatment for adult patients with chronic HypoPT? This systematic search found 1100 articles, which was reduced to 312 based on title and abstract. The working group assessed these for eligibility in more detail, and 32 full-text articles were assessed. For the final recommendations, other literature was also taken into account. Little evidence is available on how best to treat HypoPT. Data on quality of life and the risk of complications have just started to emerge, and clinical trials on how to optimize therapy are essentially non-existent. Most studies are of limited sample size, hampering firm conclusions. No studies are available relating target calcium levels with clinically relevant endpoints. Hence it is not possible to formulate recommendations based on strict evidence. This guideline is therefore mainly based on how patients are managed in clinical practice, as reported in small case series and based on the experiences of the authors.\n                  <\/jats:p>","DOI":"10.1530\/eje-15-0628","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T13:20:57Z","timestamp":1436534457000},"page":"G1-G20","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":378,"title":["European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults"],"prefix":"10.1093","volume":"173","author":[{"given":"Jens","family":"Bollerslev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores M","family":"Shoback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sitges-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van Biesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2015071010204276000_173.2.G1.1","doi-asserted-by":"crossref","unstructured":"Cusano NE Rubin MR Bilezikian JP . Parathyroid hormone therapy for hypoparathyroidism. Best Practice & Research. Clinical Endocrinology & Metabolism 2015 29 47\u201355. (doi:10.1016\/j.beem.2014.09.001).","DOI":"10.1016\/j.beem.2014.09.001"},{"key":"2015071010204276000_173.2.G1.2","doi-asserted-by":"crossref","unstructured":"Khan MI Waguespack SG Hu MI . Medical management of postsurgical hypoparathyroidism. Endocrine Practice 2011 17 (Suppl 1) 18\u201325. (doi:10.4158\/EP10302.RA).","DOI":"10.4158\/EP10302.RA"},{"key":"2015071010204276000_173.2.G1.3","unstructured":"Rejnmark L Underbjerg L Sikjaer T . Therapy of hypoparathyroidism by replacement with parathyroid hormone. Scientifica 2014 2014 765629. (doi:10.1155\/2014\/765629)."},{"key":"2015071010204276000_173.2.G1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0803050"},{"key":"2015071010204276000_173.2.G1.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0209-y"},{"key":"2015071010204276000_173.2.G1.6","doi-asserted-by":"crossref","unstructured":"Betterle C Garelli S Presotto F . Diagnosis and classification of autoimmune parathyroid disease. Autoimmunity Reviews 2014 13 417\u2013422. (doi:10.1016\/j.autrev.2014.01.044).","DOI":"10.1016\/j.autrev.2014.01.044"},{"key":"2015071010204276000_173.2.G1.7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1206"},{"key":"2015071010204276000_173.2.G1.8","doi-asserted-by":"crossref","unstructured":"Underbjerg L Sikjaer T Mosekilde L Rejnmark L . Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. Journal of Bone and Mineral Research 2013 28 2277\u20132285. (doi:10.1002\/jbmr.1979).","DOI":"10.1002\/jbmr.1979"},{"key":"2015071010204276000_173.2.G1.9","doi-asserted-by":"crossref","unstructured":"Underbjerg L Sikjaer T Mosekilde L Rejnmark L . The epidemiology of non-surgical hypoparathyroidism in Denmark: a nationwide case finding study. Journal of Bone and Mineral Research 2015 In press doi:10.1002\/jbmr.2501).","DOI":"10.1002\/jbmr.2501"},{"key":"2015071010204276000_173.2.G1.10","doi-asserted-by":"crossref","unstructured":"Powers J Joy K Ruscio A Lagast H . Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. Journal of Bone and Mineral Research 2013 28 2570\u20132576. (doi:10.1002\/jbmr.2004).","DOI":"10.1002\/jbmr.2004"},{"key":"2015071010204276000_173.2.G1.11","unstructured":"Lorente-Poch L Sancho JJ Munoz-Nova JL Sanchez-Velazquez P Sitges-Serra A . Defining the syndromes of parathyroid failure after total thyroidectomy. Gland Surgery 2015 4 82\u201390."},{"key":"2015071010204276000_173.2.G1.12","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9384"},{"key":"2015071010204276000_173.2.G1.13","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7219"},{"key":"2015071010204276000_173.2.G1.14","doi-asserted-by":"crossref","unstructured":"Barczynski M Cichon S Konturek A . Which criterion of intraoperative iPTH assay is the most accurate in prediction of true serum calcium levels after thyroid surgery? Langenbeck's Archives of Surgery 2007 392 693\u2013698. (doi:10.1007\/s00423-007-0165-6).","DOI":"10.1007\/s00423-007-0165-6"},{"key":"2015071010204276000_173.2.G1.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-008-9545-5"},{"key":"2015071010204276000_173.2.G1.16","doi-asserted-by":"crossref","unstructured":"Lorente-Poch L Sancho JJ Ruiz S Sitges-Serra A . Importance of in situ preservation of parathyroid glands during total thyroidectomy. British Journal of Surgery 2015 102 359\u2013367. (doi:10.1002\/bjs.9676).","DOI":"10.1002\/bjs.9676"},{"key":"2015071010204276000_173.2.G1.17","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460215"},{"key":"2015071010204276000_173.2.G1.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1239"},{"key":"2015071010204276000_173.2.G1.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb04153.x"},{"key":"2015071010204276000_173.2.G1.20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.470"},{"key":"2015071010204276000_173.2.G1.21","doi-asserted-by":"crossref","unstructured":"Underbjerg L Sikjaer T Mosekilde L Rejnmark L . Postsurgical hypoparathyroidism \u2013 risk of fractures, psychiatric diseases, cancer, cataract, and infections. Journal of Bone and Mineral Research 2014 29 2504\u20132510. (doi:10.1002\/jbmr.2273).","DOI":"10.1002\/jbmr.2273"},{"key":"2015071010204276000_173.2.G1.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1808"},{"key":"2015071010204276000_173.2.G1.23","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080803"},{"key":"2015071010204276000_173.2.G1.24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021736"},{"key":"2015071010204276000_173.2.G1.25","doi-asserted-by":"crossref","unstructured":"Cooper MS . Disorders of calcium metabolism and parathyroid disease. Best Practice & Research. Clinical Endocrinology & Metabolism 2011 25 975\u2013983. (doi:10.1016\/j.beem.2011.07.001).","DOI":"10.1016\/j.beem.2011.07.001"},{"key":"2015071010204276000_173.2.G1.26","doi-asserted-by":"publisher","DOI":"10.1210\/er.18.6.832"},{"key":"2015071010204276000_173.2.G1.27","unstructured":"Kovacs CS Fuleihan G . Calcium and bone disorders during pregnancy and lactation. Endocrinology and Metabolism Clinics of North America 2006 35 21\u201351, v. (doi:10.1016\/j.ecl.2005.09.004)."},{"key":"2015071010204276000_173.2.G1.28","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00014.2014"},{"key":"2015071010204276000_173.2.G1.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-0005(98)80028-1"},{"key":"2015071010204276000_173.2.G1.30","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390284"},{"key":"2015071010204276000_173.2.G1.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6500.955"},{"key":"2015071010204276000_173.2.G1.32","doi-asserted-by":"crossref","unstructured":"Krysiak R Kobielusz-Gembala I Okopien B . Hypoparathyroidism in pregnancy. Gynecological Endocrinology 2011 27 529\u2013532. (doi:10.3109\/09513590.2010.507284).","DOI":"10.3109\/09513590.2010.507284"},{"key":"2015071010204276000_173.2.G1.33","doi-asserted-by":"publisher","DOI":"10.1177\/000992280504400312"},{"key":"2015071010204276000_173.2.G1.34","doi-asserted-by":"crossref","unstructured":"Demirel N Aydin M Zenciroglu A Okumus N Cetinkaya S Yildiz YT Ipek MS . Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress. Annals of Tropical Paediatrics 2009 29 149\u2013154. (doi:10.1179\/146532809X440770).","DOI":"10.1179\/146532809X440770"},{"key":"2015071010204276000_173.2.G1.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(70)80245-1"},{"key":"2015071010204276000_173.2.G1.36","doi-asserted-by":"crossref","unstructured":"Loughead JL Mughal Z Mimouni F Tsang RC Oestreich AE . Spectrum and natural history of congenital hyperparathyroidism secondary to maternal hypocalcemia. American Journal of Perinatology 1990 7 350\u2013355. (doi:10.1055\/s-2007-999521).","DOI":"10.1055\/s-2007-999521"},{"key":"2015071010204276000_173.2.G1.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39582.589433.BE"},{"key":"2015071010204276000_173.2.G1.38","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.483"},{"key":"2015071010204276000_173.2.G1.39","doi-asserted-by":"crossref","unstructured":"Porter RH Cox BG Heaney D Hostetter TH Stinebaugh BJ Suki WN . Treatment of hypoparathyroid patients with chlorthalidone. New England Journal of Medicine 1978 298 577\u2013581. (doi:10.1056\/NEJM197803162981101).","DOI":"10.1056\/NEJM197803162981101"},{"key":"2015071010204276000_173.2.G1.40","unstructured":"Atkinson SA . The new dietary reference intakes from the Institute of Medicine for calcium and vitamin D. Perspective Infirmi\u00e8re: Revue Officielle de l'Ordre des Infirmi\u00e8res et Infirmiers du Qu\u00e9bec 2011 8 5."},{"key":"2015071010204276000_173.2.G1.41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2704"},{"key":"2015071010204276000_173.2.G1.42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1216"},{"key":"2015071010204276000_173.2.G1.43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2552"},{"key":"2015071010204276000_173.2.G1.44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1908"},{"key":"2015071010204276000_173.2.G1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2015071010204276000_173.2.G1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.012"},{"key":"2015071010204276000_173.2.G1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2015071010204276000_173.2.G1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.03.013"},{"key":"2015071010204276000_173.2.G1.49","doi-asserted-by":"crossref","unstructured":"Guyatt GH Schunemann HJ Djulbegovic B Akl EA . Guideline panels should not GRADE good practice statements. Journal of Clinical Epidemiology 2015 68 597\u2013600. (doi:10.1016\/j.jclinepi.2014.12.011).","DOI":"10.1016\/j.jclinepi.2014.12.011"},{"key":"2015071010204276000_173.2.G1.50","unstructured":"Arata RO Mautalen CA Geffner D Horwith M . Effect of hydrochlorothiazide upon serum and urinary calcium in patients with hypoparathyroidism. Medicina 1974 34 463\u2013470."},{"key":"2015071010204276000_173.2.G1.51","doi-asserted-by":"crossref","unstructured":"Mannstadt M Clarke BL Vokes T Brandi ML Ranganath L Fraser WD Lakatos P Bajnok L Garceau R Mosekilde L . Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet. Diabetes & Endocrinology 2013 1 275\u2013283. (doi:10.1016\/S2213-8587(13)70106-2).","DOI":"10.1016\/S2213-8587(13)70106-2"},{"key":"2015071010204276000_173.2.G1.52","doi-asserted-by":"crossref","unstructured":"Cusano NE Rubin MR McMahon DJ Irani D Anderson L Levy E Bilezikian JP . PTH(1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. Journal of Clinical Endocrinology and Metabolism 2014 99 3694\u20133699. (doi:10.1210\/jc.2014-2267).","DOI":"10.1210\/jc.2014-2267"},{"key":"2015071010204276000_173.2.G1.53","doi-asserted-by":"crossref","unstructured":"Sikjaer T Rolighed L Hess A Fuglsang-Frederiksen A Mosekilde L Rejnmark L . Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporosis International 2014 25 1717\u20131726. (doi:10.1007\/s00198-014-2677-6).","DOI":"10.1007\/s00198-014-2677-6"},{"key":"2015071010204276000_173.2.G1.54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1429"},{"key":"2015071010204276000_173.2.G1.55","doi-asserted-by":"crossref","unstructured":"Kannan S Mahadevan S Velayutham P Bharath R Kumaravel V Muthukumaran J Premkumar A . Estimation of magnesium in patients with functional hypoparathyroidism. Indian Journal of Endocrinology and Metabolism 2014 18 821\u2013825. (doi:10.4103\/2230-8210.141365).","DOI":"10.4103\/2230-8210.141365"},{"key":"2015071010204276000_173.2.G1.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04254-9"},{"key":"2015071010204276000_173.2.G1.57","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12511213"},{"key":"2015071010204276000_173.2.G1.58","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11321210"},{"key":"2015071010204276000_173.2.G1.59","unstructured":"Caudarella R Vescini F Buffa A Francucci CM . Hyperphosphatemia: effects on bone metabolism and cardiovascular risk. Journal of Endocrinological Investigation 2007 30 (6 Suppl) 29\u201334."},{"key":"2015071010204276000_173.2.G1.60","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft400"},{"key":"2015071010204276000_173.2.G1.61","doi-asserted-by":"crossref","unstructured":"Autier P Boniol M Pizot C Mullie P . Vitamin D status and ill health: a systematic review. Lancet. Diabetes & Endocrinology 2014 2 76\u201389. (doi:10.1016\/S2213-8587(13)70165-7).","DOI":"10.1016\/S2213-8587(13)70165-7"},{"key":"2015071010204276000_173.2.G1.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0090"},{"key":"2015071010204276000_173.2.G1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.11.018"},{"key":"2015071010204276000_173.2.G1.64","doi-asserted-by":"crossref","unstructured":"Hobaus J Thiem U Hummel DM Kallay E . Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anti-Cancer Agents in Medicinal Chemistry 2013 13 20\u201335. (doi:10.2174\/187152013804487434).","DOI":"10.2174\/187152013804487434"},{"key":"2015071010204276000_173.2.G1.65","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq342"},{"key":"2015071010204276000_173.2.G1.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)76148-1"},{"key":"2015071010204276000_173.2.G1.67","doi-asserted-by":"crossref","unstructured":"Davies M Taylor CM Hill LF Stanbury SW . 1,25-Dihydroxycholecalciferol in hypoparathyroidism. Lancet 1977 1 55\u201359. (doi:10.1016\/S0140-6736(77)91077-7).","DOI":"10.1016\/S0140-6736(77)91077-7"},{"key":"2015071010204276000_173.2.G1.68","doi-asserted-by":"crossref","unstructured":"Hill LF Davies M Taylor CM Standbury SW . Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol. Clinical Endocrinology 1976 5 (Suppl) 167S\u2013173S. (doi:10.1111\/j.1365-2265.1976.tb03824.x).","DOI":"10.1111\/j.1365-2265.1976.tb03824.x"},{"key":"2015071010204276000_173.2.G1.69","doi-asserted-by":"crossref","unstructured":"Kanis JA Russell RG Smith R . Physiological and therapeutic differences between vitamin D, its metabolites and analogues. Clinical Endocrinology 1977 7 (Suppl) 191s\u2013201s. (doi:10.1111\/j.1365-2265.1977.tb03381.x).","DOI":"10.1111\/j.1365-2265.1977.tb03381.x"},{"key":"2015071010204276000_173.2.G1.70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6053.78"},{"key":"2015071010204276000_173.2.G1.71","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-2-238"},{"key":"2015071010204276000_173.2.G1.72","unstructured":"Seino Y Tanaka H Yamaoka K Yabuuchi H . Circulating 1\u03b1,25-dihydroxyvitamin D levels after a single dose of 1\u03b1,25-dihydroxyvitamin D3 or 1\u03b1-hydroxyvitamin D3 in normal men. Bone and Mineral 1987 2 479\u2013485."},{"key":"2015071010204276000_173.2.G1.73","doi-asserted-by":"crossref","unstructured":"Recker RR Heaney RP . The effect of milk supplements on calcium metabolism, bone metabolism and calcium balance. American Journal of Clinical Nutrition 1985 41 254\u2013263.","DOI":"10.1093\/ajcn\/41.2.254"},{"key":"2015071010204276000_173.2.G1.74","doi-asserted-by":"crossref","unstructured":"Harvey JA Zobitz MM Pak CY . Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. Journal of Bone and Mineral Research 1988 3 253\u2013258. (doi:10.1002\/jbmr.5650030303).","DOI":"10.1002\/jbmr.5650030303"},{"key":"2015071010204276000_173.2.G1.75","doi-asserted-by":"publisher","DOI":"10.1177\/0115426507022003286"},{"key":"2015071010204276000_173.2.G1.76","doi-asserted-by":"crossref","unstructured":"Zamfirescu I Carlson HE . Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid 2011 21 483\u2013486. (doi:10.1089\/thy.2010.0296).","DOI":"10.1089\/thy.2010.0296"},{"key":"2015071010204276000_173.2.G1.77","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0054-y"},{"key":"2015071010204276000_173.2.G1.78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.7.2366"},{"key":"2015071010204276000_173.2.G1.79","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509990195"},{"key":"2015071010204276000_173.2.G1.80","doi-asserted-by":"crossref","unstructured":"Kurzel RB Hagen GA . Use of thiazide diuretics to reduce the hypercalciuria of hypoparathyroidism during pregnancy. American Journal of Perinatology 1990 7 333\u2013336. (doi:10.1055\/s-2007-999516).","DOI":"10.1055\/s-2007-999516"},{"key":"2015071010204276000_173.2.G1.81","doi-asserted-by":"crossref","unstructured":"Newman GH Wade M Hosking DJ . Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism. European Journal of Clinical Pharmacology 1984 27 41\u201346. (doi:10.1007\/BF02395204).","DOI":"10.1007\/BF02395204"},{"key":"2015071010204276000_173.2.G1.82","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-4-557"},{"key":"2015071010204276000_173.2.G1.83","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1986.02140160057032"},{"key":"2015071010204276000_173.2.G1.84","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90215-1"},{"key":"2015071010204276000_173.2.G1.85","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01103.x"},{"key":"2015071010204276000_173.2.G1.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.05.006"},{"key":"2015071010204276000_173.2.G1.87","doi-asserted-by":"crossref","unstructured":"Qaseem A Dallas P Forciea MA Starkey M Denberg TD . Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2014 161 659\u2013667. (doi:10.7326\/M13-2908).","DOI":"10.7326\/M13-2908"},{"key":"2015071010204276000_173.2.G1.88","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_3.16"},{"key":"2015071010204276000_173.2.G1.89","doi-asserted-by":"crossref","unstructured":"Ketteler M Elder GJ Evenepoel P Ix JH Jamal SA Lafage-Proust MH Shroff R Thadhani RI Tonelli MA Kasiske BL . Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney International 2015 87 502\u2013528. (doi:10.1038\/ki.2014.425).","DOI":"10.1038\/ki.2014.425"},{"key":"2015071010204276000_173.2.G1.90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc066308"},{"key":"2015071010204276000_173.2.G1.91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2301"},{"key":"2015071010204276000_173.2.G1.92","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-1067"},{"key":"2015071010204276000_173.2.G1.93","doi-asserted-by":"crossref","unstructured":"Touliatos JS Sebes JI Hinton A McCommon D Karas JG Palmieri GM . Hypoparathyroidism counteracts risk factors for osteoporosis. American Journal of Medical Sciences 1995 310 56\u201360. (doi:10.1097\/00000441-199508000-00003).","DOI":"10.1097\/00000441-199508000-00003"},{"key":"2015071010204276000_173.2.G1.94","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.4.1312"},{"key":"2015071010204276000_173.2.G1.95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.11.5313"},{"key":"2015071010204276000_173.2.G1.96","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.7.3068"},{"key":"2015071010204276000_173.2.G1.97","unstructured":"Caplan RH Beguin EA . Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstetrics and Gynecology 1990 76 485\u2013489."},{"key":"2015071010204276000_173.2.G1.98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03300290036018"},{"key":"2015071010204276000_173.2.G1.99","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-4-810"},{"key":"2015071010204276000_173.2.G1.100","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-24-6-512"},{"key":"2015071010204276000_173.2.G1.101","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.424"},{"key":"2015071010204276000_173.2.G1.102","doi-asserted-by":"crossref","unstructured":"Cundy T Haining SA Guilland-Cumming DF Butler J Kanis JA . Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism. Clinical Endocrinology 1987 26 667\u2013674. (doi:10.1111\/j.1365-2265.1987.tb00824.x).","DOI":"10.1111\/j.1365-2265.1987.tb00824.x"},{"key":"2015071010204276000_173.2.G1.103","doi-asserted-by":"crossref","unstructured":"Markestad T Ulstein M Bassoe HH Aksnes L Aarskog D . Vitamin D metabolism in normal and hypoparathyroid pregnancy and lactation. Case report. British Journal of Obstetrics and Gynaecology 1983 90 971\u2013976. (doi:10.1111\/j.1471-0528.1983.tb06774.x).","DOI":"10.1111\/j.1471-0528.1983.tb06774.x"},{"key":"2015071010204276000_173.2.G1.104","doi-asserted-by":"crossref","unstructured":"Rude RK Haussler MR Singer FR . Postpartum resolution of hypocalcemia in a lactating hypoparathyroid patient. Endocrinologia Japonica 1984 31 227\u2013233. (doi:10.1507\/endocrj1954.31.227).","DOI":"10.1507\/endocrj1954.31.227"},{"key":"2015071010204276000_173.2.G1.105","doi-asserted-by":"crossref","unstructured":"Shomali ME Ross DS . Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation. Endocrine Practice 1999 5 198\u2013200. (doi:10.4158\/EP.5.4.198).","DOI":"10.4158\/EP.5.4.198"},{"key":"2015071010204276000_173.2.G1.106","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5635.23"},{"key":"2015071010204276000_173.2.G1.107","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2984"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/2\/G1.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/2\/G1.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:33:06Z","timestamp":1676374386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/173\/2\/G1\/6668000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":107,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0628","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}